See below for other related events.
27-29 June 2018, Winchester, UK
The 2018 Bone Research Society Annual Meeting will take place in the historic city of Winchester, on the King Alfred Campus of the University of Winchester.
The local organisers - Claire Clarkin, Cyrus Cooper, Nick Harvey, Richard Oreffo and Kate Ward are already hard at work putting together an exciting scientific programme and we hope you will be a part of it.
12 September 2018, Birmingham, UK
This one-day training course aims to help GPs and other primary care practitioners to better manage patients with metabolic bone disease. Taking into account the restrictions of primary care and the 10 minute consultation, the course will focus on providing practical and actionable information.
The course has been approved for 6 CPD credits by the Royal College of Physicians (course code 118523).
On completion of the course, it is expected that participants will be able to:
- Assess and investigate metabolic bone diseases in primary care
- Identify when a referral to secondary care is appropriate for further management
- Understand and use latest available guidelines in metabolic bone diseases
- Confidently apply, evaluate and modify primary care treatment in response to the changing needs of the patient
Topics will cover the diagnosis and treatment of osteoporosis and other metabolic bone diseases, including:
- Raised calcium/hyperparathyroidism
- Raised alkaline phosphatase/Paget's disease
- Fracture risk assessment
- Duration of treatment and drug holidays in osteoporosis
- Calcium supplements – do we need them?
- Osteogenesis imperfecta
- Renal bone disease/osteodystrophy
Organised by Dr Richard Keen and Dr Judith Bubbear of the Royal National Orthopaedic Hospital, London, the course will be delivered by a faculty of topic experts.
18-20 March 2019, Merton College, Oxford, UK
This three-day residential training course aims to provide trainees in medical specialties such as rheumatology, endocrinology, care of the elderly, gastroenterology, orthopaedics, respiratory medicine and clinical chemistry with the knowledge and understanding to manage patients with osteoporosis and other metabolic bone diseases. The course is intended to focus on practical issues relating to patient management and is strongly recommended for any trainee who foresees that patients with these disorders will form a significant part of their workload in future. A stimulating interactive format will be employed combining lectures, panel discussions, debates and workshops. Specialist nurses in osteoporosis and falls will also find this course valuable, as well as newly qualified consultants or others wishing to update their knowledge in this field.
26-29 May 2018, Valencia, Spain
Abstract submission: 29 January 2018
Where scientific research and clinical science meet….
The ECTS programme will include:
•Invited speaker lectures featuring some of the world’s leading experts in the field
•Meet the Professor sessions
•Dedicated New Investigator sessions organised by the ECTS Academy
•Joint ECTS-ASBMR debate and lecture
•East meets West session
•A high proportion of submitted abstracts selected for the oral programme
•Well-attended poster sessions with dedicated poster viewing time
•A busy poster and exhibition area with lunch included in the delegate fee
•Company-supported satellite symposia highlighting some of the latest developments in therapy and research
7-8 June 2018, Stockholm, Sweden
13-14 June 2018, The Edge, Sheffield
Target Audience: suitable for clinicians (eg. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists, radiographers and nurses and GPs with a special interest
This two-day course applies the scientific knowledge and research expertise
developed within the Mellanby Centre and within the National Osteoporosis
Society to offer high quality training for clinicians, allied health professionals and
laboratory scientists working in the field of osteoporosis and other metabolic
bone diseases. The focus of the training is on two key topics: Bone Turnover
markers (BTM) and Vertebral Fracture Identification and participants are able to
sign up for a single day or both days.
30 June - 1 July 2018, Oxford, UK
In association with the 2018 Cancer and Bone Society Meeting.
Reviewing the latest in the discovery of novel therapies for bone and other musculoskeletal diseases.
For those who’ve attended before, you’ll know this means an exceptional meeting which combines cutting edge exciting science with a friendly and supportive atmosphere, and which encourages discussion and collaboration both in and out of the lecture theatre. Interaction between senior international scientists, clinicians and more junior researchers is particularly encouraged.
2-3 July 2018, Oxford, UK
Abstract submission: 23 February 2018
In association with the 8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases (MolPharm)
5-7 July 2018, Dublin, Ireland
FFN invites you to join the 7th FFN Global Congress 2018 in Dublin, Ireland from 5–7 July 2018. The annual meeting is an international congress addressing the full pathway of care for fragility fracture patients. Its themes include perioperative care, surgical treatment, rehabilitation, secondary prevention, research and policy change. The FFN Global Congress consists of invited international experts, plenary discussions, update sessions and free papers. The congress provides a unique platform to learn about new technical developments, state-of-the-art procedures and interaction with leading clinicians, researchers and other professional health workers and stake holders. This year’s motto is “Patient centred multidisciplinary care”.
17 August 2018, Dundee, UK
The Brittle Bone Society in conjunction with the Medical Advisory Board will host the second annual Scientific Symposium. The programme is designed to reflect a broad range of topics relevant to the care of patients with Osteogenesis Imperfecta.
1-4 September 2018, Lage Vuursche, Netherlands
The course starts with an “introductory session” where key topics relevant to skeletal research are covered, followed by a varied programme that incorporates clinical and basic topics with a mix of speakers with clinical or basic science backgrounds. An example of the topics likely to be included in the programme is provided below. One of the important aspects of the course is the opportunity for students to network and obtain feedback on their project. Student presentations include poster and short presentations of their PhD project as well as networking sessions with invited speakers. The course has been of immense value to previous participants, and the networks that form during these events help to sustain the musculoskeletal field in Europe into the future.
6-8 September 2018, Helsinki, Finland
Abstract submission deadline: 20 April 2018 & Early registration deadline: 29 June 2018: 29 June 2018
The programme will cover the topics:
Prosthetic joint infection: diagnosis, treatment, prevention
Traumatology - treatment of bone infection in tibia, pelvis, ankle and calcaneus
Plastic Surgery - role of flap reconstruction in bone and joint infections, reconstruction of tissue defects after prosthetic joint infection of the knee
Biomaterials – role of bone substitutes in the treatment of infected bone
14 September 2018, Leeds, UK
This annual event is widely recognised as the leading meeting in the UK for clinicians working in the field of falls and mobility medicine. The day provides a forum for scientific discussion and clinical updates and enables a multidisciplinary audience of over 200 professionals to share their experiences of best clinical practice.
8-10 November 2018, Bankok, Thailand
17-19 March 2019, Bruges, Belgium
4-7 April 2019, Paris, France
9-12 April 2019, Cardiff
22-25 June 2019, Salzburg, Austria
Deadline for abstracts: 15 February 2019
ICCBH meetings provide an international forum for the presentation and discussion of current basic and clinical science in the field of bone metabolism and bone mass in children, adolescents and young adults.